Sugi Predict

Sugi Predict / Compounds / SCHEMBL525596

SCHEMBL525596

SCHEMBL525596

CN(C(=O)n1cnc(-c2ccc(S(=O)(=O)N(Cc3ccccc3)Cc3ccccc3)cc2)c1)C1CCN(Cc2ccccc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 2/20 0.47
▸ CES2 O00748 1/20 0.47
▸ DRD2 P14416 3/20 0.46
▸ DRD4 P21917 1/20 0.46
▸ DRD3 P35462 1/20 0.46
▸ HTR2A P28223 2/20 0.46
▸ HTR2C P28335 2/20 0.46
▸ HTR2B P41595 2/20 0.46
▸ SIGMAR1 Q99720 2/20 0.46
▸ CCR4 P51679 1/20 0.46
▸ CXCR4 P61073 2/20 0.44
▸ NR1H2 P55055 1/20 0.43
▸ OPRM1 P35372 1/20 0.43
▸ ADORA2B P29275 1/20 0.43
▸ CHRM4 P08173 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CHRM2 P08172 1/20 0.42
▸ CHRM3 P20309 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL425036 0.89 KCNH2 (0.50) FAAHCES2DRD2DRD4DRD3
SCHEMBL427523 0.89 FAAH (0.49) FAAHCES2DRD2DRD4DRD3
SCHEMBL424816 0.87 DRD2 (0.57) FAAHCES2DRD2DRD4DRD3
SCHEMBL428152 0.85 DRD2 (0.50) FAAHCES2DRD2DRD4DRD3
SCHEMBL14950181 0.85 DRD2 (0.50) FAAHCES2DRD2DRD4DRD3
SCHEMBL426011 0.85 DRD2 (0.50) FAAHCES2DRD2DRD4DRD3
SCHEMBL427768 0.85 OPRM1 (0.53) FAAHCES2DRD2DRD4DRD3
SCHEMBL427522 0.85 DRD2 (0.49) FAAHCES2DRD2DRD4DRD3
SCHEMBL527421 0.83 CHRM2 (0.53) FAAHCES2DRD2DRD4DRD3
SCHEMBL426100 0.83 DRD2 (0.47) FAAHCES2DRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2606035-B1 PROCES FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA S A (PT) 2017-09-06 — — EP disclosed
US-9458111-B2 Process for the synthesis of substituted urea compounds BIAL—PORTELA & CA, S.A. (PT) 2016-10-04 — — US disclosed
US-9458111-B2 Process for the synthesis of substituted urea compounds BIAL—PORTELA & CA, S.A. (PT) 2016-10-04 — — US disclosed
US-9458111-B2 Process for the synthesis of substituted urea compounds BIAL—PORTELA & CA, S.A. (PT) 2016-10-04 — — US disclosed
EP-2606035-A1 PROCES FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - Portela & CA., S.A. (PT) 2013-06-26 — — EP disclosed
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2013-05-16 — — US disclosed
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2013-05-16 — — US disclosed
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2013-05-16 — — US disclosed
WO-2012015324-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2012-02-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123493-A1 PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS UTS2R, ARG1, PRMT1 FAAH 2166/4885CES2 463/4885DRD2 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.